Latest filing published 16 Aug 2021 for Eliem Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
AI ETI LLC: trading record in brief
AI ETI LLC discloses dealings in Climb Bio, Inc. to SEC (Form 4). Activity is concentrated on a single trading day, 12 August 2021, with 2 filings.
On the market, this insider has only ever bought: 1 purchase, €8.5M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 16 August 2021, the filings show an open-market purchase worth €8.5M in Climb Bio, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to AI ETI LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,209,400 shares0Common StockSEC:0001209191-21-051627:0
1 of 1 declaration